Topics - Cytotoxics and High Potency Manufacturing
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published January 14, 2013
Adds to manufacturing capabilities Read More »
By Tom Spurgeon, Contract Pharma
Published September 6, 2012
Fortune and opportunity in a burgeoning class of therapies Read More »
By Gil Y. Roth, Contract Pharma
Published May 4, 2012
Patheon's CEO talks about his first year on the job Read More »
By Gil Roth
Published April 4, 2012
The president of Pfizer CentreSource talks about the company's move into development services. Read More »
By Andrea Wagner
Published April 4, 2012
Pairing the product, package and process for parenterals Read More »
By Bernd Schummelfeder and Cristin Grove
Published April 4, 2012
Requirements for outsourcing high containment development activities Read More »
Published April 4, 2012
More opportunities, but greater regulatory scrutiny Read More »
Published March 27, 2012
commended for commitment to aseptic processing and filling capabilities Read More »
Published March 12, 2012
Invests more than £500k in new vial filling equipment Read More »
By S. Harachand, Contributing Editor
Published March 7, 2012
Expansions, exits and much more Read More »
By Gil Roth
Published March 7, 2012
Business is up while companies stake out new territories Read More »
By Gil Roth
Published February 2, 2012
Hlass takes responsibility for custom synthesis, manufacturing services Read More »
By Gil Roth
Published December 27, 2011
Quality issues to derail sterile injectables till 4Q12 Read More »
By Gil Roth
Published October 18, 2011
Stason to make oral oncology products for Amerigen Read More »
